All 6,886 procedure codes billed by Medicaid providers in California, ranked by total spending.
| # | Code | Description | Total Paid |
|---|---|---|---|
| 1 | T1015 | Clinic visit/encounter, all-inclusive | $21.79B |
| 2 | H2015 | Comprehensive community support services, per 15 minutes | $8.35B |
| 3 | 00003 | Internal/system code - not a standard HCPCS code | $5.32B |
| 4 | S5102 | Day care services, adult; per diem | $3.29B |
| 5 | 90999 | Unlisted dialysis procedure, inpatient or outpatient | $3.28B |
| 6 | H2010 | Comprehensive medication services, per 15 minutes | $3.19B |
| 7 | H2017 | Psychosocial rehabilitation services, per 15 minutes | $3.02B |
| 8 | T1017 | Targeted case management, each 15 minutes | $2.63B |
| 9 | 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | $2.26B |
| 10 | H2019 | Therapeutic behavioral services, per 15 minutes | $2.07B |
| 11 | 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | $1.79B |
| 12 | 90837 | Psychotherapy, 53 minutes with patient | $1.72B |
| 13 | 99283 | Emergency department visit for the evaluation and management, moderate severity | $1.65B |
| 14 | 0450 | Emergency room services | $1.61B |
| 15 | S9484 | Crisis intervention mental health services, per hour | $1.56B |
| 16 | H0019 | Behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem | $1.54B |
| 17 | H0032 | Mental health service plan development by non-physician | $1.49B |
| 18 | T2031 | Assisted living; waiver, per diem | $1.44B |
| 19 | 99284 | Emergency department visit for the evaluation and management, high severity | $1.23B |
| 20 | 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | $1.22B |
| 21 | D0120 | Periodic oral evaluation - established patient | $923.63M |
| 22 | A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | $915.11M |
| 23 | H0004 | Behavioral health counseling and therapy, per 15 minutes | $909.13M |
| 24 | H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | $863.75M |
| 25 | G0300 | Direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting, each 15 minutes | $802.46M |
| 26 | H0034 | Medication training and support, per 15 minutes | $733.14M |
| 27 | D1120 | Prophylaxis - child | $724.81M |
| 28 | U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $668.51M |
| 29 | A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | $589.55M |
| 30 | 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | $575.75M |
| 31 | D0150 | Comprehensive oral evaluation - new or established patient | $572.23M |
| 32 | 99215 | Prolong outpt/office vis | $571.70M |
| 33 | H2011 | Crisis intervention service, per 15 minutes | $568.11M |
| 34 | H0018 | Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem | $566.12M |
| 35 | A0425 | Ground mileage, per statute mile | $558.63M |
| 36 | H2013 | Psychiatric health facility service, per diem | $532.82M |
| 37 | 0659 | Rehabilitation services, other | $495.81M |
| 38 | 99233 | Prolong inpt eval add15 m | $489.44M |
| 39 | G9012 | Other specified case management service not elsewhere classified | $467.60M |
| 40 | 74177 | Computed tomography, abdomen and pelvis; with contrast material | $442.98M |
| 41 | 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | $428.97M |
| 42 | A0130 | Non-emergency transportation: wheelchair van | $426.00M |
| 43 | 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | $422.58M |
| 44 | 99232 | Subsequent hospital care, per day, moderate complexity | $396.58M |
| 45 | H0005 | Alcohol and/or drug services; group counseling by a clinician | $363.50M |
| 46 | D0230 | Intraoral - periapical each additional radiographic image | $363.22M |
| 47 | 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | $349.80M |
| 48 | 90834 | Psychotherapy, 45 minutes with patient | $348.02M |
| 49 | 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | $340.53M |
| 50 | 99281 | Emergency department visit for the evaluation and management, self-limited or minor | $331.05M |
| 51 | A0380 | Bls mileage (per mile) | $323.46M |
| 52 | D2930 | Prefabricated stainless steel crown - primary tooth | $315.33M |
| 53 | 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | $314.31M |
| 54 | G0299 | Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes | $310.14M |
| 55 | T4541 | Incontinence product, disposable underpad, large, each | $308.03M |
| 56 | D1110 | Prophylaxis - adult | $307.74M |
| 57 | 70450 | Computed tomography, head or brain; without contrast material | $302.18M |
| 58 | 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | $302.12M |
| 59 | G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | $285.95M |
| 60 | 80053 | Comprehensive metabolic panel | $283.80M |
| 61 | 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | $283.24M |
| 62 | 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | $275.32M |
| 63 | 99223 | Prolong inpt eval add15 m | $273.95M |
| 64 | S9124 | Nursing care, in the home; by licensed practical nurse, per hour | $267.53M |
| 65 | D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | $264.41M |
| 66 | 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | $249.97M |
| 67 | T2005 | Non-emergency transportation; stretcher van | $246.15M |
| 68 | G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | $233.90M |
| 69 | 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | $233.33M |
| 70 | 97153 | Adaptive behavior treatment by protocol, administered by technician, each 15 minutes | $232.14M |
| 71 | G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | $231.66M |
| 72 | G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | $226.11M |
| 73 | J3490 | Unclassified drugs | $223.01M |
| 74 | 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | $222.53M |
| 75 | D1351 | Sealant - per tooth | $221.92M |
| 76 | D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | $215.14M |
| 77 | D1208 | Topical application of fluoride, excluding varnish | $206.75M |
| 78 | 77067 | Screening mammography, bilateral, including computer-aided detection | $203.90M |
| 79 | T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | $199.56M |
| 80 | D2150 | Silver amalgam - two surfaces, primary or permanent | $196.33M |
| 81 | J9271 | Injection, pembrolizumab, 1 mg | $195.70M |
| 82 | G9008 | Coordinated care fee, physician coordinated care oversight services | $195.17M |
| 83 | T1019 | Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) | $195.13M |
| 84 | 0121 | $195.04M | |
| 85 | 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | $194.75M |
| 86 | 0510 | $193.86M | |
| 87 | 0821 | $185.29M | |
| 88 | D0210 | Intraoral - complete series of radiographic images | $183.77M |
| 89 | D1310 | $181.05M | |
| 90 | T2033 | Residential care, not otherwise specified (nos), waiver; per diem | $180.35M |
| 91 | 67028 | Intravitreal injection of a pharmacologic agent | $178.30M |
| 92 | H0031 | Mental health assessment, by non-physician | $177.55M |
| 93 | 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | $176.66M |
| 94 | E0784 | External ambulatory infusion pump, insulin | $175.88M |
| 95 | 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | $175.45M |
| 96 | D7140 | Extraction, erupted tooth or exposed root | $175.15M |
| 97 | 0658 | $171.66M | |
| 98 | E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | $168.87M |
| 99 | D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | $168.76M |
| 100 | H0006 | Alcohol and/or drug services; case management | $167.52M |
| 101 | 88305 | Level IV - Surgical pathology, gross and microscopic examination | $162.36M |
| 102 | 78815 | Positron emission tomography (PET) for limited area imaging | $162.24M |
| 103 | D2751 | Crown - porcelain fused to predominantly base metal | $160.04M |
| 104 | 74176 | Computed tomography, abdomen and pelvis; without contrast material | $160.01M |
| 105 | 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | $158.95M |
| 106 | 0120 | $157.79M | |
| 107 | 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | $156.96M |
| 108 | 59425 | $153.61M | |
| 109 | H0043 | Supported housing, per diem | $152.42M |
| 110 | 99199 | Unlisted special service, procedure or report | $151.42M |
| 111 | 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | $149.29M |
| 112 | 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | $148.93M |
| 113 | 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | $147.14M |
| 114 | 0650 | Inj, levothyroxine, hikma | $146.90M |
| 115 | 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | $146.44M |
| 116 | 71045 | Radiologic examination, chest; single view | $144.74M |
| 117 | D0274 | Bitewings - four radiographic images | $142.36M |
| 118 | H2012 | Behavioral health day treatment, per hour | $140.22M |
| 119 | 97530 | Therapeutic activities, direct patient contact, each 15 minutes | $138.78M |
| 120 | D2391 | Resin-based composite - one surface, posterior, primary or permanent | $138.61M |
| 121 | D8670 | Periodic orthodontic treatment visit | $135.66M |
| 122 | 90832 | Psychotherapy, 30 minutes with patient | $134.57M |
| 123 | 00069 | $132.25M | |
| 124 | 99205 | Prolong outpt/office vis | $131.54M |
| 125 | J0178 | Injection, aflibercept, 1 mg | $130.17M |
| 126 | A0390 | Als mileage (per mile) | $130.02M |
| 127 | A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | $129.50M |
| 128 | 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | $127.24M |
| 129 | A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | $126.09M |
| 130 | 96130 | $122.92M | |
| 131 | D9223 | Deep sedation/general anesthesia - each subsequent 15 minute increment | $122.21M |
| 132 | G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | $121.58M |
| 133 | G0378 | Hospital observation service, per hour | $119.96M |
| 134 | 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | $119.60M |
| 135 | G0151 | Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes | $119.04M |
| 136 | 81408 | $119.04M | |
| 137 | 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | $118.86M |
| 138 | G9002 | Coordinated care fee, maintenance rate | $118.25M |
| 139 | 71046 | Radiologic examination, chest; 2 views | $117.35M |
| 140 | V5298 | Hearing aid, not otherwise classified | $116.65M |
| 141 | 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | $116.24M |
| 142 | G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | $116.13M |
| 143 | D3330 | Endodontic therapy, molar tooth (excluding final restoration) | $115.86M |
| 144 | D1206 | Topical application of fluoride varnish | $115.45M |
| 145 | 96375 | Therapeutic injection; each additional sequential IV push | $114.50M |
| 146 | 99282 | Emergency department visit for the evaluation and management, low to moderate severity | $110.93M |
| 147 | T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | $108.95M |
| 148 | 90791 | Psychiatric diagnostic evaluation | $108.88M |
| 149 | D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | $107.91M |
| 150 | H0012 | Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient) | $105.80M |
| 151 | 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | $102.58M |
| 152 | D4341 | $102.00M | |
| 153 | 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | $101.22M |
| 154 | G0463 | Hospital outpatient clinic visit for assessment and management of a patient | $100.98M |
| 155 | 84443 | Thyroid stimulating hormone (TSH) | $100.76M |
| 156 | T1026 | Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per hour | $99.79M |
| 157 | T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | $98.95M |
| 158 | Z7502 | $98.17M | |
| 159 | 90945 | $97.11M | |
| 160 | D0350 | $97.02M | |
| 161 | T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | $96.76M |
| 162 | D2740 | Crown - porcelain/ceramic | $96.73M |
| 163 | 81519 | $95.75M | |
| 164 | J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | $94.66M |
| 165 | E0465 | Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube) | $94.05M |
| 166 | D9430 | $93.42M | |
| 167 | 99499 | $92.54M | |
| 168 | 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | $91.90M |
| 169 | 45380 | Colonoscopy, flexible; with biopsy, single or multiple | $91.79M |
| 170 | A4351 | Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each | $91.47M |
| 171 | 0360 | $90.38M | |
| 172 | 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | $89.64M |
| 173 | 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | $89.01M |
| 174 | D9993 | $88.79M | |
| 175 | U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | $88.73M |
| 176 | A0100 | Non-emergency transportation; taxi | $88.58M |
| 177 | D0272 | Bitewings - two radiographic images | $88.04M |
| 178 | A4230 | Infusion set for external insulin pump, non needle cannula type | $87.19M |
| 179 | 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | $87.08M |
| 180 | 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | $86.49M |
| 181 | D2140 | $85.88M | |
| 182 | 80061 | Lipid panel | $85.83M |
| 183 | 90847 | Family psychotherapy with the patient present, 50 minutes | $85.76M |
| 184 | 0160 | $85.33M | |
| 185 | H0046 | Mental health services, not otherwise specified | $83.84M |
| 186 | 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | $83.63M |
| 187 | S9083 | Global fee urgent care centers | $83.22M |
| 188 | 81508 | $83.05M | |
| 189 | S9977 | Meals, per diem, not otherwise specified | $83.03M |
| 190 | 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | $81.60M |
| 191 | 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | $80.68M |
| 192 | 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | $80.22M |
| 193 | 0250 | $79.85M | |
| 194 | 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | $79.29M |
| 195 | 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | $78.55M |
| 196 | D0220 | Intraoral - periapical first radiographic image | $78.33M |
| 197 | 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | $77.85M |
| 198 | E0466 | Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell) | $77.85M |
| 199 | 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | $77.81M |
| 200 | 0551 | $77.47M |